These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 26022567)

  • 1. Communicating the role and value of vaccine adjuvants.
    Gellin BG; Salisbury DM
    Vaccine; 2015 Jun; 33 Suppl 2():B44-6. PubMed ID: 26022567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination adjuvants: the next generation of adjuvants?
    Mutwiri G; Gerdts V; van Drunen Littel-van den Hurk S; Auray G; Eng N; Garlapati S; Babiuk LA; Potter A
    Expert Rev Vaccines; 2011 Jan; 10(1):95-107. PubMed ID: 21162624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spectroscopic characterization of antibodies adsorbed to aluminium adjuvants: correlation with antibody vaccine immunogenicity.
    Capelle MA; Brügger P; Arvinte T
    Vaccine; 2005 Feb; 23(14):1686-94. PubMed ID: 15705473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccine adjuvants: role and mechanisms of action in vaccine immunogenicity.
    Marciani DJ
    Drug Discov Today; 2003 Oct; 8(20):934-43. PubMed ID: 14554157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid and carbohydrate based adjuvant/carriers in immunology.
    McGeary RP; Olive C; Toth I
    J Pept Sci; 2003 Jul; 9(7):405-18. PubMed ID: 12916638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of particle size and antigen binding on effectiveness of aluminum salt adjuvants in a model lysozyme vaccine.
    Clausi A; Cummiskey J; Merkley S; Carpenter JF; Braun LJ; Randolph TW
    J Pharm Sci; 2008 Dec; 97(12):5252-62. PubMed ID: 18398901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of size on particulate vaccine adjuvants.
    Shah RR; O'Hagan DT; Amiji MM; Brito LA
    Nanomedicine (Lond); 2014 Dec; 9(17):2671-81. PubMed ID: 25529570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvants for veterinary vaccines--types and modes of action.
    Gerdts V
    Berl Munch Tierarztl Wochenschr; 2015; 128(11-12):456-63. PubMed ID: 26697712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oil-based emulsion vaccine adjuvants.
    Schijns VEJC; Strioga M; Ascarateil S
    Curr Protoc Immunol; 2014 Aug; 106():2.18.1-2.18.7. PubMed ID: 25081910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The path forward.
    De Gregorio E
    Vaccine; 2015 Jun; 33 Suppl 2():B60-3. PubMed ID: 26022572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unmet needs in modern vaccinology: adjuvants to improve the immune response.
    Leroux-Roels G
    Vaccine; 2010 Aug; 28 Suppl 3():C25-36. PubMed ID: 20713254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physicochemical and functional characterization of vaccine antigens and adjuvants.
    Dey AK; Malyala P; Singh M
    Expert Rev Vaccines; 2014 May; 13(5):671-85. PubMed ID: 24702271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Overview of Novel Adjuvants Designed for Improving Vaccine Efficacy.
    Bonam SR; Partidos CD; Halmuthur SKM; Muller S
    Trends Pharmacol Sci; 2017 Sep; 38(9):771-793. PubMed ID: 28668223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aluminium-adjuvanted vaccines--a review of the current state of knowledge.
    Gołoś A; Lutyńska A
    Przegl Epidemiol; 2015; 69(4):731-4, 871-4. PubMed ID: 27139352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccine Ingredients: Components that Influence Vaccine Efficacy.
    Kocourkova A; Honegr J; Kuca K; Danova J
    Mini Rev Med Chem; 2017; 17(5):451-466. PubMed ID: 27488583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. When an aluminium adjuvant is not an aluminium adjuvant used in human vaccination programmes.
    Exley C
    Vaccine; 2012 Mar; 30(12):2042. PubMed ID: 22041301
    [No Abstract]   [Full Text] [Related]  

  • 17. Strategies to link innate and adaptive immunity when designing vaccine adjuvants.
    Garlapati S; Facci M; Polewicz M; Strom S; Babiuk LA; Mutwiri G; Hancock RE; Elliott MR; Gerdts V
    Vet Immunol Immunopathol; 2009 Mar; 128(1-3):184-91. PubMed ID: 19042032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccines with aluminum-containing adjuvants: optimizing vaccine efficacy and thermal stability.
    Clapp T; Siebert P; Chen D; Jones Braun L
    J Pharm Sci; 2011 Feb; 100(2):388-401. PubMed ID: 20740674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. One does not fit all: new adjuvants are needed and vaccine formulation is critical.
    Korsholm KS
    Expert Rev Vaccines; 2011 Jan; 10(1):45-8. PubMed ID: 21162619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opportunities and challenges of Web 2.0 for vaccination decisions.
    Betsch C; Brewer NT; Brocard P; Davies P; Gaissmaier W; Haase N; Leask J; Renkewitz F; Renner B; Reyna VF; Rossmann C; Sachse K; Schachinger A; Siegrist M; Stryk M
    Vaccine; 2012 May; 30(25):3727-33. PubMed ID: 22365840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.